Business
GB Sciences Wins Louisiana State University (LSU) Bid to Act as LSU Agricultural Center's Exclusive Operator of Medical Cannabis Production Facility
GB Sciences Wins Louisiana State University (LSU) Bid to Act as LSU Agricultural Center's Exclusive Operator of Medical Cannabis Production Facility.
About this update from Gb Sciences, Inc.
[{"type":"text","content":"\n\n\n\nGB Sciences Wins Louisiana State University (LSU) Bid to Act as LSU Agricultural Center's Exclusive Operator of Medical Cannabis Production Facility\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nGB Sciences Wins Louisiana State University (LSU) Bid to Act as LSU Agricultural Center's Exclusive Operator of Medical Cannabis Production Facility\nThe LSU Agricultural Center has one of the only two licenses granted by the State of Louisiana to cultivate, distribute and sell medical cannabis. In addition, GB Sciences will have first rights to commercialize any inventions or discoveries of the research center.\nPR Newswire\nLAS VEGAS, June 26, 2017\n\n\n\n\n \n\n \n \n\n\nLAS VEGAS, June 26, 2017 /PRNewswire/ -- GB Sciences, Inc. (OTCQB: GBLX) secures bid to Louisiana State University (LSU) and receives authorization from the LSU Board of Supervisors to proceed with contract negotiations to act as the LSU Agricultural Center's (AgCenter) licensed operator of their medical cannabis production facility as outlined in the Alison Neustrom Act (hereinafter referred to as the \"Act\").  The secured bid will enable GB Sciences to be the sole vendor of cannabis and extracted cannabis compounds on behalf of LSU for the patients of Louisiana.  The agricultural centers at LSU and Southern University have the only two licenses granted by the State of Louisiana to cultivate, distribute, and sell medical cannabis.\n\n\n \n \n\n \nThe Act specifically authorizes the LSU AgCenter to conduct research on medical cannabis.  The AgCenter will operate a separate independent research division alongside and in the same facility as the Production Entity's commercial operation, which will produce therapeutic medical cannabis products for qualified patients of Louisiana. GB Sciences will have first rights to commercialize any inventions or discovery of the research. \n\nThe facility will serve people who live in the state of Louisiana.  The cultivation plant will contain a minimum of a 5,000 square foot research lab. The license and partnership is for the development o...